Micro Emerging Active

VR Adviser acquista Spyre Therapeutics

New narrative with limited coverage — still forming.

Punteggio
0,2
Velocità
▲ 0,0
Articoli
2
Fonti
1

Top Movers

TickerSettoreVariazione
SYRE
Healthcare+61,1%

Sentiment Timeline

Performance Settoriale

Stock Performance

Event Timeline

Apr 08, 2026
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 … Neutral
Mar 19, 2026
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools Neutral

Articoli Correlati

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools

Nasdaq · Mar 19, 2026

Cronologia

Prima apparizioneMar 19, 2026
Ultimo aggiornamentoMar 19, 2026